[Table/Fig-1]:
Groups | Male | Female |
---|---|---|
Ebastine 20 mg- Group A | 30(20%) | 20(13.3%) |
Ebastine 10 mg -Group B | 29(19.3%) | 21(14%) |
Levocetirizine 5 mg -Group C | 21(14%) | 29(19.3%) |
Total | 80(53.3%) | 70(46.6%) |
Groups | Male | Female |
---|---|---|
Ebastine 20 mg- Group A | 30(20%) | 20(13.3%) |
Ebastine 10 mg -Group B | 29(19.3%) | 21(14%) |
Levocetirizine 5 mg -Group C | 21(14%) | 29(19.3%) |
Total | 80(53.3%) | 70(46.6%) |